Cargando…
National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management
On January 9 2020, the World Health Organization (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a disease (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9 2020, WHO decl...
Autores principales: | Nicastri, Emanuele, Petrosillo, Nicola, Ascoli Bartoli, Tommaso, Lepore, Luciana, Mondi, Annalisa, Palmieri, Fabrizio, D’Offizi, Gianpiero, Marchioni, Luisa, Murachelli, Silvia, Ippolito, Giuseppe, Antinori, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097833/ https://www.ncbi.nlm.nih.gov/pubmed/32218915 http://dx.doi.org/10.4081/idr.2020.8543 |
Ejemplares similares
-
Elevated P-Selectin in Severe Covid-19: Considerations for Therapeutic Options
por: Agrati, Chiara, et al.
Publicado: (2021) -
Aero-Medical Evacuation during SARS-CoV-2 Pandemic: Extraordinary Measure or Emerging Treatment Option?
por: Benvenuto, Domenico, et al.
Publicado: (2022) -
Bufo & Spallanzani
por: Fonseca, Rubem -
Lazzaro Spallanzani
por: Franchini, Guiseppe
Publicado: (1930) -
The Shadowed Side of Spallanzani
por: Hamilton, James B.
Publicado: (1934)